Identifying delays to mechanical thrombectomy for acute stroke: Onset to door and door to clot times

Journal of NeuroInterventional Surgery

Volumn 6, Issue 7, 2014, Pages 505-510

  Asif, Kaiz S ^a   Lazzaro, Marc A ^a   Zaidat, Osama ^a  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING; EMERGENCY HEALTH SERVICE; ENDOVASCULAR SURGERY; HUMAN; PATIENT TRANSPORT; STATISTICS AND NUMERICAL DATA; STROKE; THROMBECTOMY; TIME TO TREATMENT;

BLOOD COAGULATION; EMERGENCY MEDICAL SERVICES; ENDOVASCULAR PROCEDURES; HUMANS; PATIENT TRANSFER; STROKE; THROMBECTOMY; TIME-TO-TREATMENT;

EID: 84905912695     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2013-010792     Document Type: Review

References (56)

1. Lansberg MG, Schrooten M, Bluhmki E, et al. Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke 2009;40:2079-84.
2. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
3. Lees KR, Bluhmki E, Von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-703.
4. Saver JL, Jahan R, Levy EI, et al. Time is brain - quantified. Stroke 2006;37:263-6. (Pubitemid 43732089)
5. Del Zoppo GJ, Saver JL, Jausch E, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945-8.
6. Alexandrov AV, Burgin W, Demchuk A, et al. Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001;103:2897-902. (Pubitemid 32578125)
7. Khatri P, Abruzzo T, Yeatts S, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-72.
8. Broderick JP, Palesch YY, Demchuk AM. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013;368:893-903.
9. Marler J. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke, NINDS.August1997.NIH Publication No.97-4239.
10. Alberts MJ, Hademenos G, Latchaw R, et al. Recommendations for the establishment of primary stroke centers. Brain attack coalition. JAMA 2000;283:3102-9. (Pubitemid 30399721)
11. Adams HP Jr, Del Zoppo GJ, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-711. (Pubitemid 46691097)
12. Alberts MJ, Latchaw R, Jagoda A, et al. Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the brain attack coalition. Stroke 2011;42:2651-65.
13. Evenson KR, Foraker R, Morris D, et al. A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke 2009;4:187-99.
14. Fonarow GC, Smith E, Saver J, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 min. Circulation 2011;123:750-8.
15. Fonarow GC, Smith E, Saver J, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association 's Target: Stroke initiative. Stroke 2011;42:2983-9.
16. Leifer D, Bravata D, Connors J, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:849-77.
17. Bae HJ, Kim D, Yoo N, et al. Prehospital notification from the emergency medical service reduces the transfer and intra-hospital processing times for acute stroke patients. J Clin Neurol 2010;6:138-42.
18. Patel MD, Rose K, O'Brien E, et al. Prehospital notification by emergency medical services reduces delays in stroke evaluation: findings from the North Carolina stroke care collaborative. Stroke 2011;42:2263-8.
19. Kothari R, Jausch E, Broderick E, et al. Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med 1999;33:3-8. (Pubitemid 29028773)
20. Lacy CR, Suh D, Beuno M, et al. Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (S.T.R.O.K.E.). Stroke 2001;32:63-9. (Pubitemid 32063825)
21. Rossnagel K, Jungehulsing G, Nolte C, et al. Out-of-hospital delays in patients with acute stroke. Ann Emerg Med 2004;44:476-83. (Pubitemid 39425049)
22. Rose KM, Rosamond W, Hutson S, et al. Predictors of time from hospital arrival to initial brain-imaging among suspected stroke patients: the North Carolina Collaborative Stroke Registry. Stroke 2008;39:3262-7.
23. Prehospital and hospital delays after stroke onset-Units States. MMWR Morb Mortality Weekly Report May 18, 2007/56(19):474-478.
24. Morgenstern LB, Staub L, Cha W, et al. Improving delivery of acute stroke therapy: the TLL Temple Foundation Stroke Project. Stroke 2002;33:160-6. (Pubitemid 34052204)
25. Crocco TJ. NAEMSP Prehospital Emergency Care; 2007;11:313-17.
26. Strbian D, Meretoja A, Ahlhelm F, et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology 2012;78:427-32.
27. Lindsberg PJ, Happola O, Kallela M, et al. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology 2006;67:334-6. (Pubitemid 44305430)
28. Mahler SA, Chan H, Carden D, et al. Emergency department activation of interventional cardiology to reduce door-to-balloon time. West J Emerg Med 2010;11:363-6.
29. Singer AJ, Shembaker A, Visram F, et al. Emergency department activation of an interventional cardiology team reduces door-to-balloon times in ST-segment-elevation myocardial infarction. Ann Emerg Med 2007;50:538-44. (Pubitemid 47600399)
30. Kraft PL, Newman S, Hanson D, et al. Emergency physician discretion to activate the cardiac catheterization team decreases door-to-balloon time for acute ST-elevation myocardial infarction. Ann Emerg Med 2007;50:520-6. (Pubitemid 47600380)
31. Kontos MC, Kurz M, Robert C, et al. An evaluation of the accuracy of emergency physician activation of the cardiac catheterization laboratory for patients with suspected ST-segment elevation myocardial infarction. Ann Emerg Med 2010;55:423-30.
32. Whelley-Wilson C, Newman G. A stroke scale for emergency triage. J Stroke Cerebrovasc Dis 2004;13:247-53. (Pubitemid 39470025)
33. Miley JT, Memon M, Hussein H, et al. A multicenter analysis of 'time to microcatheter ' for endovascular therapy in acute ischemic stroke. J Neuroimaging 2011;21:159-64.
34. Grotta JC, Savitz SI, Persse D. Stroke severity and time should determine triage. Stroke 2013;44:555-7.
35. Silbergleit R, Scott P, Lowell M, et al. Cost-effectiveness of helicopter transport of stroke patients for thrombolysis. Acad Emerg Med 2003;10:966-72. (Pubitemid 37093200)
36. Silliman S, Quinn B, Haggett V, et al. Use of a field-to-stroke center helicopter transport program to extend thrombolytic therapy to rural residents. Stroke 2003;34:729-33. (Pubitemid 36307402)
37. Prabhakaran S, Ward E, John S, et al. Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke 2011;42:1626-30.
38. Smith WS, Sung G, Storkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8. (Pubitemid 40967507)
39. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-12. (Pubitemid 351440692)
40. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 h of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633-9. (Pubitemid 47493996)
41. Machi P, Costalat V, Lobotesis K, et al. Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg 2012;4:62-6.
42. Wolfe T, Suarez J, Tarr R, et al. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 2008;17:121-8. (Pubitemid 351626608)
43. Shaltoni HM, Albright K, Gonzalez N, et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007;38:80-4. (Pubitemid 46035610)
44. Mattle H, Arnold M, Giorgiadis D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379-83. (Pubitemid 351619459)
45. Meretoja A, Strbian D, Mustanoja S, et al. Reducing in-hospital delay to 20 min in stroke thrombolysis. Neurology 2012;79:306-13.
46. Latchaw R, Alberts M, Lev M, et al. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke 2009;40:3646-78.
47. Lansberg M, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 2012;11:860-7.
48. Kidwell CS, Jahan R, Gornbein J. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368:914-23.
49. Jovin T, Liebeskind D, Gupta R, et al. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 h from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke 2011;42:2206-11.
50. Salottolo K, Fanale C, Leonard K, et al. Multimodal imaging does not delay intravenous thrombolytic therapy in acute stroke. AJNR Am J Neuroradiol 2011;32:864-8.
51. Sheth KN, Terry JB, Nogueira RG. Advanced modality imaging evaluation in acute ischemic stroke may lead to delayed endovascular reperfusion therapy without improvement in clinical outcomes. J Neurointerv Surg 2013;5(Suppl 1):i62-5.
52. Froehler M, Fifi J, Majid A, et al. Anesthesia for endovascular treatment of acute ischemic stroke. Neurology 2012;79(13 Suppl 1):S167-73.
53. Brekenfeld C, Mattle H, Shroth G. General is better than local anesthesia during endovascular procedures. Stroke 2010;41:2716-17.
54. Abou-Chebl A, Lin R, Hussain M, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke 2010;41:1175-9.
55. Hassan A, Chaudhry S, Miley J, et al. Microcatheter to recanalization (procedure time) predicts outcomes in endovascular treatment in patients with acute ischemic stroke: when do we stop? AJNR Am J Neuroradiol 2013;34:354-9.
56. Saver J, Jehan R, Levy E, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380:1241-9.